Thursday, November 25, 2004
|
|
Pre-Congress course on IVF & ART:
Is there a recipe for success?
The aim: To give a comprehensive update for practitioners
in clinical and laboratory aspects of assisted reproduction
Chairmen:
R.Frydman,France V.Gomel,Canada Z.Ben Rafael, Israel |
|
|
Investigation
of the Infertile Couple
| Chairman: |
V. Gomel, Canada |
| R. Frydman, France |
|
|
| 1. |
Are laparoscopy and hysteroscopy necessary before
IVF?
V. Gomel, Canada
|
|
| 2. |
Assessment of ovarian follicular status in practice
R. Frydman, France |
|
| 3. |
Immunologic infertility. Does it really exist? IVF perspective
R. Kurzawa, Poland |
|
| 4. |
Is LH supplementation necessary?
S. Kolibianakis, Belgium |
|
| |
Panel Discussion |
|
|
Ovarian Stimulation Regimens
| Chairmen: |
Z. Ben Rafael, Israel |
| |
S.L Tan, Canada |
|
|
| 1. |
Aggressive or mild controlled ovarian hyperstimulation.
What predominates: benefits or health hazards?
M. Szamatowicz, Poland
|
|
| 2. |
Antagonists versus agonists? What to prefer?
A. DeCherney, USA
|
|
| 3. |
Poor responders and IVF
Z. Ben-Rafael, Israel |
|
| 4. |
When to cancel an IVF cycle?
D. Levran, Israel
|
|
| |
Panel Discussion |
|
|
Embryo Transfer
| Chairmen: |
V. Gomel, Canada |
| |
Z. Shoham, Israel |
|
|
| 1. |
How to improve embryo transfer
R. Frydman, France
|
|
| 2. |
Single versus two or more embryo transfer
V. Gomel, Canada |
|
| 3. |
PGD- can it increase pregnancy rate?
Y. Verlinsky, USA |
|
| 4. |
The 1 embryo transfer in treatment cycles of IVF: Cost-effective
for whom?
C. Jones, UK
|
|
| |
Panel Discussion |
|
Improving Success Rate Through Newer
Techniques
| Chairmen: |
Y. Verlinsky, USA |
| |
R. Frydman, France |
|
|
| 1. |
In-vitro maturation
S.L. Tan, Canada
|
|
| 2. |
Frozen banking of follicles
S. Kim, USA
|
|
| 3. |
New markers for endometrial receptivity
N. Malhotra, India
|
|
| 4. |
Can we improve implantation - clinical aspects
Z. Shoham, Israel
|
|
| |
Panel Discussion |
|
| |
|
|
A. Infertility and ART |
|
| Cloning and Stem Cells |
|
|
| Capsule: Are we stepping
into the dark? Can we differentiate between the risks and benefits?
|
|
| Chairmen: |
A. DeCherney, USA |
| |
R. Frydman, France |
|
| 1. |
Cloned human embryonic stem cells and its potential application
W-S. Hwang, Korea |
|
| 2. |
Technical aspects of establishment of human embryonic stem
cells by somatic cell
Nuclear transfer
S.K. Kang, Korea |
|
| 3. |
Sex selection for non-genetic reasons
Y. Verlinsky, USA |
|
|
| Serono Industrial
Symposium: Improving ART Outcome |
|
| 1. |
Introduction
C.M. Howles, Singapore |
| 2. |
All you wanted to know about improving quality in the
Embryology Lab
C. Sjoblom, UK |
|
| 3. |
Setting new standards of treatment with Gonal-f FbM
G. Trew, UK |
|
| 4. |
Optimising patient compliance with the Gonal-f FbM
Prefilled Pen
R. Porter, Australia |
|
| |
|
Endometriosis
| Chairmen: |
G.K. Tripathi, India |
| |
V. Gomel, Canada |
|
|
| Capsule:Can we choose
between the many options of therapy of this poorly understood
condition? |
|
| 1. |
Michelin guide to surgery
P. Koninckx, Belgium |
|
| 2. |
Endometrioma: IVF or operation - which comes first?
R. Frydman, France |
|
| 3. |
Surgical vs. medical therapy
P. Koninckx, Belgium
|
|
| 4. |
Hormonal suppressive therapy of endometriosis - are we really
improving the patient's health?
Z. Blumenfeld, Israel |
|
|
Treatment before ART
| Chairmen: |
H. Pattnaik, India |
| |
Z. Shoham, Israel |
|
|
| Capsule: Does the
high success rate of IVF and the possibility to control multiple
pregnancy dictate progressing directly to IVF? |
|
| 1. |
Should treatment with clomiphene citrate continue? What should
we offer to failures?
A. Weissman, Israel |
|
| 2. |
Is IUI mandatory before IVF? Natural versus stimulated cycle
S.L. Tan, Canada |
|
| 3. |
Should we proceed directly to IVF? Reducing the multiple
pregnancies risks
N. Gleicher, USA |
|
| |
|
|
|
PCOS
| Chairpersons: |
S.L. Tan, Canada |
| |
A. Rojanasakul, Thailand |
|
|
| Capsule: The most
common endocrinopathy remains an enigma in many aspects |
|
| 1. |
Should Metformin be used routinely for all women
with PCOS?
J. Tank, India |
|
| 2. |
Risk of OHSS - is it a real problem?
Z. Ben-Rafael, Israel |
| 3. |
Minimal monitoring of ovarian stimulation - is it safe?
Z. Shoham, Israel |
|
| 4. |
Ovarian surgery for PCOS. Why is it not more popular?
A. Rojanasakul, Thailand |
|
|
Minimal Workup Before Infertility Treatment
| Chairpersons: |
S. Daya, Canada |
| |
S. Kim, USA |
|
|
| Capsule: Can we do
without some of the tests? |
|
| 1. |
Basal hormonal test - are they required?
J. Dor, Israel |
|
| 2. |
Is sophisticated sperm analysis ever required?
J.P. Shah, India |
|
| 3. |
Simplification of IVF
L-C. Cheng, Singapore |
|
| 4. |
Kleinfelter syndrome: should we treat by IVF?
J. Dor, Israel |
|
New Technologies in IVF
| Chairmen: |
Y. Verlinsky, USA |
| |
W-S. Hwang, Korea |
|
|
| Capsule: With all
the technological improvements the question remains, are we
progressing? |
|
| 1. |
PGD analysis, pregnancies and live births following blastocyst
biopsy
S.J. Mcarthur, Australia |
|
| 2. |
Biological benefit of PGD-AS: Selection by inclusion, exclusion
or preferation
A.G. Schmutzler, Germany |
|
| 3. |
Preimplantation HLA matching
S. J. Mcarthur, Australia |
|
| 4. |
Free fetal DNA and prenatal diagnosis
R. Dhallan, USA |
|
Practical IVF
| Chairmen: |
J. Dor, Israel |
| |
T. Vutyavanich, Thailand |
|
|
| Capsule: Many practical
issues are unsettled |
|
| 1. |
Should we limit the number of embryo transferred
N. Gleicher, USA |
|
| 2. |
GIFT and ZIFT. Why are they disappearing?
A. DeCherney, USA |
|
| 3. |
What can affect success during embryo transfer?
S. Daya, Canada |
|
| 4. |
Should we transfer on day 3 or day 5?
S. Kolibianakis, Belgium |
|
Hot Controversies
| Chairmen: |
N. Gleicher, USA |
| |
J. Kotarski, Poland
|
|
|
| 1. |
Preservation of fertility in-spite of chemotherapy
in women-Present practice and future endeavours / hopes
Z. Blumenfeld, Israel |
|
| 2. |
New understandings from embryo analysis in assisted reproductive
technologies
T. Stojanov, Australia |
|
| 3. |
GnRh agonists v/s antagonists?
D. Shah, India |
|
| 4. |
Cumulative fetal heart pregnancy rate after elective single
embryo transfer (eSET) as the blastocyst stage
K.A. De Boer, Australia |
| 5. |
Comparison of endometrial and subendometrial blood flow measured
by three-dimensional power Doppler ultrasound between stimulated
and natural cycles in the same patients
E.H.Y. Ng, Hong Kong |
| 6. |
Laparoscopic spectral analysis of lesions of endometriosis
L. Demco, Canada |
|
Pregnancy Loss
| Chairmen: |
S. Daya, Canada |
| |
S. Wolczynski, Poland |
|
|
| Capsule: Confusion
exists over the treatment of this common condition |
|
| 1. |
Early pregnancy loss in IVF, is there any treatment?
D. Levran, Israel
|
|
| 2. |
Can PGD overcome recurrent pregnancy failure?
Y. Verlinsky, USA |
|
| 3. |
Maternal autoimmune disease can it affect future generations?
N. Gleicher, USA |
|
| 4. |
The end of immunotherapy
S. Daya, Canada |
|
| 5. |
The role of thyroid hormone in early pregnancy maintenance
H. Matsuo, Japan
|
| |
|
|
|
Conservative Treatment of Fibroids
| Chairmen: |
V. Gomel, Canada |
| |
Z. Ben-Rafael, Israel |
|
|
| 1. |
Current state of fibroids embolization
J. Kotarski, Poland |
| 2. |
Management of intramural fibroids in infertility - is it
important?
T. Kar, India |
| 3. |
Myomectomy during CS
Z. Ben-Rafael, Israel |
| 4. |
Endoscopy and minimum invasive management of fibroid uterus
in infertility
O. Shawki, Egypt |
B. Gynecology/Menopause and Family Planning
|
|
|
Endoscopy and Ablation
| Chairmen: |
S. Corson, USA |
| |
P. Chaisilpwattana, Poland |
| |
G. Jakiel, Poland |
|
|
| 1. |
Endometrial ablation - What? When? Why?
K.W. Lee, Singapore |
|
| 2. |
Laparoscopic hysterectomy - can we reduce the risks to the
uterus?
M. East, New Zealand |
|
| 3. |
Title to be confirmed
R. Zurawin, USA |
|
|
Sponsored Symposium by Schering
The Drospirenone Benefit From Contraception To Post-Menopause
Chairperson: T. Surasek |
|
| 1. |
Progestins: are they all the same
D. Mansour, UK |
|
| 2. |
Yasmin: added value in contraception
R. Arias, USA |
|
| 3. |
New insights in HRT controversies post WHI
R. Sitruk - Ware, USA |
|
| 4. |
The effect of different progestins in HRT and the
cardiovascular issue
P. Collins, UK |
|
Organon Sponsored Session: Time to
Livial
| Chairmen: |
Z. Shoham, Israel |
| |
K. Papadopoulos, Greece |
|
|
| 1. |
HRT-where are we?
Z. Shoham, Israel |
|
| 2. |
Tibolone: a selective tissue estrogenic activity regulator
K. I. Papadopoulos, Greece |
|
| 3. |
Understanding women's loss of sexual desire
S. Davis, Australia |
|
| 4. |
The specific effects of tibolone on the breast
R. Baber, Australia |
| 5. |
General discussion |
|
Family Planning - endorsed by the Tarnesby
Chair of Fertility Regulation
| Chairpersons: |
R. Arias, USA |
| |
R. Zurawin, USA |
|
|
| 1. |
Innovations and technology in intrauterine contraceptive
devices : better future
O. Shawki, Egypt |
|
| 2. |
Will the patch replace the Pill?
S. Radowicki, Poland |
|
| 3. |
The future of permanent female contraception
R. Zurawin, USA
|
|
| 4. |
Effectiveness, acceptability and side-effects of Implanon
in Switzerland - a retrospective study by the Implanon Swiss
Study Group (ISSG)
J. Bitzer, Switzerland |
|
Laparoscopy
| Chairmen: |
S. Corson, USA |
| |
S.K. Mohapatra, India |
|
|
| Capsule: Laparoscopy
is emerging as a practical tool in advanced surgery
|
|
| 1. |
Transvaginal 3 -D US with serum 125 level for diagnosis of
pelvic adhesions before laparoscopic surgery
K-M. Seow, Taiwan |
|
| 2. |
Laparoscopic transabdominal cervicoisthmic cerclage during
pregnancy
F. Nezhat, USA |
|
| 3. |
Laparoscopic removal of large myomas
R. Sinha, India |
|
| 4. |
GnRh analogues before hysterectomy or myomectomy
S. Corson, USA |
|
|
Sponsored Symposium by Schering
More Than Effective Contraception - Mirena IUS |
|
| 1. |
A unique category in contraception
R. Sitruk-Ware, USA |
|
| 2. |
The importance of counseling
R. Arias, USA |
|
| 3. |
Contraception with additional benefits
D. Mansour, UK |
|
| 4. |
Mirena use according to life stage
I.S. Fraser, Australia |
|
|
Gynecological Malignancy
| Chairmen: |
D. Kansal, India |
| |
P.E. Schwartz, USA |
|
|
| 1. |
HPV DNA typing has no role in the routine evaluation of the
abnormal Pap smear
P.E. Schwartz, USA |
|
| 2. |
The role of laparoscopy in Gynecological malignancies
F. Nezhat, USA |
|
| 3. |
Which route for hysterectomy in dub cases?
R. Sinha, India |
|
|
| Ovarian Cancer: Screening and Prophylactic
Oophorectomy |
|
| Capsule: Delayed
diagnosis of ovarian cancer is the major problem affecting prognosis
- can we diagnose it earlier? |
| 1. |
Prophylactic oophorectomy in BRCA carriers with or without
hysterectomy
P.E. Schwartz, USA |
|
| 2. |
Algorithmic diagnosis of endometrial cancer in menopausal
age
T. Pertynski, Poland |
|
| 3. |
Incidental prophylactic oophorectomy during abdominal surgery
P.E. Schwartz, USA |
|
| 4. |
The place of biochemical testing
R. Pagadala, India |
|
|
Hot Controversies
| Chairmen: |
I.S. Fraser, Australia |
| |
V. Linasmita, Thailand |
|
|
| 1. |
The mirena vs. Copper IUD - sonographic and doppler flow
evaluation
Y. Zalel, Israel |
|
| 2. |
Clampless vaginal hysterectomy
G.K. Tripathi, India |
|
| 3. |
A new strategy in the treatment of female urinary incontinence
T. Rechberger, Poland |
|
| 4. |
Rectus fascia sling for stress urinary incontinence
R. Sinha, India |
|
| Treating Menopausal Women Under the
WHI Shadow |
|
Capsule: WHI results
indicates an increase risk of CVD, does it also indicate the
end of HRT?
| Chairpersons: |
R. Sitruk-Ware, USA
T. Paszkowski, Poland |
| |
|
|
|
| 1. |
Critical evolution of WHI results
R. Arias, USA |
|
| 2. |
Has WHI data any value for current practice?
J. Studd, UK |
| 3. |
WHI: The Progestin story
R. Sitruk-Ware, USA |
| 4. |
Testosterone for Postmenopausal Women
J. Studd, UK |
|
| Hot Controversies |
|
| 1. |
Estrogen and progesterone receptor expression by macrophage
and regulation of hepatocyte growth factor y ovarian steroids
in women with endometriosis
K. Newaz Khan, Japan |
|
| 2. |
PCOS silent killer- how to prevent PCOS long term health
hazards
L. Pawelczyk, Poland |
|
| 3. |
Endometrial cryoablation
L. Weather, USA |
|
| Ovarian Cancer: Screening and Prophylactic
Oophorectomy |
|
| Capsule: Delayed
diagnosis of ovarian cancer is the major problem affecting prognosis
- can we diagnose it earlier |
|
| 1. |
Prophylactic oophorectomy in BRCA carriers with or without
hysterectomy
P.E. Schwartz, USA |
|
| 2. |
Algorithmic diagnosis of endometrial cancer in menopausal
age
T. Pertynski, Poland |
| 3. |
Incidental prophylactic oophorectomy during abdominal surgery
P.E. Schwartz, USA |
|
| 4. |
The place of biochemical testing
R. Pagadala, India |
|
| |
|
| C. Perinatology and Prenatal Diagnosis |
|
|
Fetal Monitoring
| Chairmen: |
G. Di Renzo, Italy |
| |
W. Thitadilok, Thailand |
|
|
| Capsule: After 30
years of experience, the question remains |
|
| 1. |
Is there a place for electronic fetal monitoring in the low
risk patient?
R. H. Paul, USA
|
|
| 2. |
CTG and medical litigation
J. Tank, India |
| 3. |
Does it increase CS rate? Is there an optimal CS rate?
R. H. Paul, USA |
|
Prenatal Screening and Diagnosis
| Chairmen: |
S. Lipitz, Israel |
| |
D. Charoenvidjya, Thailand |
|
|
| Capsule: There is
still no agreed policy on how best to screen for fetal anomalies
|
|
| 1. |
Prenatal ultrasound screening is best done in the first trimester
P.K. Shah, India |
|
| 2. |
The role of ultrasound markers in the first trimester
A. Tan, Singapore |
| 3. |
The traditional 4-chamber view - is it enough?
Y. Zalel, Israel |
| 4. |
3D and 4D ultrasound is a gimmick?
S. Degani, Israel |
|
Gestational Diabetes
| Chairmen: |
L.G. Keith, USA |
| |
N-O. Sjoberg, Sweden |
|
|
| Capsule: Despite
increasing knowledge basic aspects are still unclear |
|
| 1. |
Should we screen and how?
G. Yeo, Singapore |
|
| 2. |
Can fetal weight be estimated accurately?
S. Lipitz, Israel |
|
| 3. |
Can macrosomia be prevented?
A. Wizniter, Israel |
|
| 4. |
Can shoulder dystocia be prevented?
I. Blickstein, Israel |
|
|
Premature Labor
| Chairmen: |
I. Blickstein, Israel |
| |
J. Deprest, Belgium |
|
|
Capsule: The major
risk facing the newborns are premature labor - can we prevent
the complications?
|
|
| 1. |
Preterm birth in multiples: can we do more?
I. Blickstein, Israel |
|
| 2. |
Antenatal prevention of severe perinatal neurological morbidity
G.C.Di Renzo, Italy |
|
| 3. |
Monochorionic twin pregnancy: complications, their management
and proposed follow up algorithm
J. Deprest, Belgium |
| 4. |
2D & 3D Doppler in the evaluation of IUGR
S. Degani, Israel |
|
|
Coping With Infection in Obstetrics
| Chairmen: |
Z. Hagay, Israel |
|
J. Rath, India |
|
|
| Capsule: Controversies
exist regarding aspects of screening and management of infectious
disease during pregnancy |
|
| 1. |
HIV in pregnancy - What's next?
P. Winit, Thailand
|
|
| 2. |
Intaamniotic infection - molecular aspects and clinical controversies
K. Drews, Poland
|
|
| 3. |
CMV - time for screening?
Z. Hagay, Israel |
|
| 4. |
Detection of subclinical infection in preterm labour and
delivery - what is the role of amniotic membranes and myometrium?
T. Laudanski, Poland
|
|
|
PPH-Post Partum Hemorrhage Prevention
and Treatment
| Chairmen: |
G. Breborowicz, Poland |
| |
Y. Herabutya, Thailand |
|
|
| Capsule: PPH remains
a major threat for mothers |
|
| 1. |
Prevention and management of PPH; is the first choice Oxytocin
or Misoprostol?
C.Y. Seng, Singapore |
|
| 2. |
Surgical options for PPH; Internal Iliac should be the choice
& then hysterectomy
J. Malhotra, India |
|
| 3. |
Recombinant factor VIIc in the management of major postpartum
hemorrhage
G. Breborowicz, Poland |
|
| 4. |
Medical treatment for PPH: oxytocin vs. methylergometrine
K. Takeuchi, Japan |
|
|
Severe Pre-eclampsia without Complications
| Chairmen: |
M. Mongelli, Australia |
| |
I. Blickstein, Israel |
|
|
| Capsule: Can we decrease
mortality and morbidity in complicated cases? |
|
| 1. |
Prediction of pre-eclampsia
B. Chanrachakul, Thailand |
| 2. |
Severe pre-eclampsia at the limit of viability - Is there
a role for expected management?
B. Anklesaria, India |
|
| 3. |
Is MgSO4 for prevention or only therapeutic?
Y. Tannirandorn, Thailand |
|
|
Intrauterine Growth Restriction
| Chairmen: |
G.C. Di Renzo, Italy |
| |
R. Debski, Poland |
|
|
| Capsule: What are
the most appropriate strategies for preventing complications
due to growth problems? |
|
| 1. |
Epidemiology and perinatal sequelae
M. Mongelli, Australia |
|
| 2. |
Fetal growth in twins
I. Blickstein, Israel |
|
| 3. |
Ultrasound and clinical assessment of fetal growth
M. Mongelli, Australia
|
|
| |
|
|
|
Hot Controversies
| Chairman: |
T.A. Choudhary, Bangladesh |
| |
L.G. Keith, USA |
|
|
| 1. |
Merits of adding 3D to 2D U/S in the examination of the fetal
skeleton
A. Ebrashy, Egypt |
|
| 2. |
The continuing tragedy of maternal mortality; Are we doing
enough? Can we do more?
I. Yoles, Israel |
| 3. |
Validity of cervical sonography versus Bishop’s score
to predict vaginal delivery in induced labors
L.R. Clemente Chua, The Philippines |
| 4. |
Soluble hla-dr and soluble cd95 ligand levels in pregnant
women with antiphosholipid syndromes
E. Ronin-Walknowska, Poland |
| 5. |
Determination of uric acid sensitivity in detecting of preeclampsia
and its severity
M. Fakhri, Iran |
| 6. |
An increase in the absolute count of CD69 expressing NK cells
in the peripheral blood is associated with recurrent miscarriage
and poor IVF-ET treatment outcome.
M.Y. Thum, UK |
|
Complications of Pregnancy and Postnatal
Care
| Chairmen: |
E. Shinwell, Israel |
| |
D.K. Patnaik, India |
|
|
| Capsule: State of
the art: care for the fetus and newborn in 2004 - where is the
evidence? |
|
| 1. |
Postnatal steroid therapy and other adverse influences on
the neonatal brain
E. Shinwell, Israel
|
|
| 2. |
CS on demand
M. Mongelli, Australia
|
|
| 3. |
The role of vaginal birth after Caesarian section
C.N. Purandare |
|
| 4. |
Surfactant and other respiratory therapy - is there any hard
evidence?
E. Shinwell, Israel |
|
Hot Controversies over Delivery
| Chairmen: |
L.G. Keith, USA |
| |
S. Suthutvoravut, Thailand |
|
|
| Capsule: Many questions
over the risks of delivery remain unanswered |
|
| 1. |
Is there any controversy over breech deliveries? External
cephalic version in modern obstetrics - risk vs. benefits?
N. Agarwal, India |
|
| 2. |
Who is afraid of the older mother of multiples?
L. G. Keith, USA |
|
| 3. |
Cord around the neck is significant for obstetrics outcome
P.K. Shah, India |
|
| 4. |
Who's afraid of triplets; should we always reduce triplets?
I. Blickstein, USA |
|
| 5. |
Myomectomy during Cesarean section: A Prospective study
B. Affandi, Indonesia
|
